A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease.

E Ruether; R Husmann; E Kinzler; E Diabl; D Klingler; J Spatt; R Ritter; Reinhold Schmidt; Z Taneri; W Winterer; D Koper; S Kasper; M Rainer; H Moessler

doi:10.1097%2F00004850-200109000-00002

A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease.

E Ruether
, R Husmann
, E Kinzler
, E Diabl
, D Klingler
, J Spatt
, R Ritter
, Reinhold Schmidt
, Z Taneri
, W Winterer
, D Koper
, S Kasper
, M Rainer
, H Moessler

Universitätsklinik für Neurologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

40 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	International Clinical Psychopharmacology
DOIs	https://doi.org/10.1097%2F00004850-200109000-00002
Publikationsstatus	Veröffentlicht - 2001

Wissenschaftszweige

302 Klinische Medizin

Zugriff auf Dokument

10.1097%2F00004850-200109000-00002

Andere Dateien und Links

Dieses zitieren

Ruether, E., Husmann, R., Kinzler, E., Diabl, E., Klingler, D., Spatt, J., Ritter, R., Schmidt, R., Taneri, Z., Winterer, W., Koper, D., Kasper, S., Rainer, M., & Moessler, H. (2001). A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease. International Clinical Psychopharmacology. https://doi.org/10.1097%2F00004850-200109000-00002

@article{9518537cbd6f4f3e898efd03f011c4c2,

title = "A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease.",

author = "E Ruether and R Husmann and E Kinzler and E Diabl and D Klingler and J Spatt and R Ritter and Reinhold Schmidt and Z Taneri and W Winterer and D Koper and S Kasper and M Rainer and H Moessler",

year = "2001",

doi = "10.1097\%2F00004850-200109000-00002",

language = "English",

journal = "International Clinical Psychopharmacology",

issn = "0268-1315",

publisher = "Lippincott Williams and Wilkins",

}

Ruether, E, Husmann, R, Kinzler, E, Diabl, E, Klingler, D, Spatt, J, Ritter, R, Schmidt, R, Taneri, Z, Winterer, W, Koper, D, Kasper, S, Rainer, M & Moessler, H 2001, 'A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease.', International Clinical Psychopharmacology. https://doi.org/10.1097%2F00004850-200109000-00002

TY - JOUR

T1 - A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease.

AU - Ruether, E

AU - Husmann, R

AU - Kinzler, E

AU - Diabl, E

AU - Klingler, D

AU - Spatt, J

AU - Ritter, R

AU - Schmidt, Reinhold

AU - Taneri, Z

AU - Winterer, W

AU - Koper, D

AU - Kasper, S

AU - Rainer, M

AU - Moessler, H

PY - 2001

Y1 - 2001

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000170745800002

UR - https://pubmed.ncbi.nlm.nih.gov/11552768

U2 - 10.1097%2F00004850-200109000-00002

DO - 10.1097%2F00004850-200109000-00002

M3 - Research article

C2 - 11552768

SN - 0268-1315

JO - International Clinical Psychopharmacology

JF - International Clinical Psychopharmacology

ER -